US HB148 | 2019-2020 | 116th Congress

Status

Spectrum: Partisan Bill (Democrat 3-0)
Status: Introduced on January 3 2019 - 25% progression, died in committee
Action: 2019-01-25 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Allows states to receive federal payment under Medicaid for 50% of their costs for providing education on the risk of renal medullary carcinoma to individuals with sickle cell disease. (Renal medullary carcinoma is a rare kidney disease usually found in individuals with the sickle cell trait.)

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Byron Nash Renal Medullary Carcinoma Awareness Act of 2019

Sponsors


History

DateChamberAction
2019-01-25HouseReferred to the Subcommittee on Health.
2019-01-03HouseReferred to the House Committee on Energy and Commerce.
2019-01-03HouseIntroduced in House

Subjects


US Congress State Sources


Bill Comments

feedback